a month ago
SEPN
AnalystsCatherine NovackCatherine Novack's Stock Forecasts
AnalystsCatherine Novack
Analyst Ranking
Top 26%
#1389 out of 5511 analysts
Average Return
+7.91%
Win Rate
31%9 out of 29
Risk vs Reward
Poor
Good
Catherine Novack's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | +326.22% | $27.27 | $116.23 | 2025-03-25 - 2026-03-24 | Strong Buy |
Regulus Therapeutics IncRGLS | +248.47% | $2.29 | $7.98 | 2024-05-31 - 2025-04-30 | Strong Buy |
Capricor Therapeutics IncCAPR | +193.63% | $10.05 | $29.51 | 2025-06-25 - 2026-06-24 | Strong Buy |
Dyne Therapeutics IncDYN | +105.07% | $10.05 | $20.61 | 2025-06-26 - 2026-06-25 | Strong Buy |
Kezar Life Sciences IncKZR | +93.51% | $53.90 | $104.30 | 2021-07-20 - 2022-07-20 | Strong Buy |
Catherine Novack Analyst Color
Get additional color on Catherine Novack's coverage of popular stocks
Catherine Novack's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vogenx IncVOGX | 1 | Strong Buy | $55.00 | +70.75% | Initiates Coverage On | 15 days ago |
Septerna IncSEPN | 2 | Strong Buy | $62.00 | +59.55% | Maintains | a month ago |
Capricor Therapeutics IncCAPR | 3 | Hold | N/A | N/A | Downgrades | 2 months ago |
Proqr Therapeutics NvPRQR | 2 | Strong Buy | $10.00 | +443.48% | Maintains | 3 months ago |
Spruce Biosciences IncSPRB | 1 | Strong Buy | $135.00 | +144.72% | Initiates Coverage On | 3 months ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $30.00 | +353.86% | Assumes | 5 months ago |
Ibio IncIBIO | 1 | Strong Buy | $7.00 | +488.24% | Initiates Coverage On | 6 months ago |
Korro Bio IncKRRO | 2 | Hold | N/A | N/A | Downgrades | 10 months ago |
Aardvark Therapeutics IncAARD | 1 | Strong Buy | $33.00 | +557.37% | Initiates Coverage On | a year ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Femasys IncFEMY | 2 | Strong Buy | $120.00 | N/A | Maintains | a year ago |
Regulus Therapeutics IncRGLS | 2 | Hold | $7.00 | N/A | Downgrades | a year ago |
Rallybio CorpRLYB | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Equillium IncEQ | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Wave Life Sciences IncWVE | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 2 years ago |
Dare Bioscience IncDARE | 2 | Strong Buy | $13.00 | N/A | Maintains | 2 years ago |
Rezolute IncRZLT | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Calcimedica IncCALC | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 3 years ago |
Kezar Life Sciences IncKZR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Purple Biotech LtdPPBT | 1 | Strong Buy | $1,600.00 | N/A | Initiates Coverage On | 3 years ago |
Omega Therapeutics IncOMGAQ | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 4 years ago |
Decibel Therapeutics IncDBTX | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Amryt Pharma PLCAMYT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.